Onderneming NovMetaPharma Co., Ltd.
Aandelen
A229500
KR7229500004
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.430 KRW | +1,50% | -13,95% | -73,51% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Health Functional Food
100,0
%
| 31 | 100,0 % | 14 | 100,0 % | -56,00% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 31 | 100,0 % | 14 | 100,0 % | -56,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hoi-Yoon Jung
CEO | Chief Executive Officer | 45 | - |
Seon-Wook Hwang
CEO | Chief Executive Officer | 64 | 04-11-10 |
Heon-Jong Lee
BRD | Director/Board Member | 54 | 01-04-11 |
Johan Auwerx
BRD | Director/Board Member | - | - |
Chun-Su Lee
AUD | Comptroller/Controller/Auditor | 62 | 31-03-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Johan Auwerx
BRD | Director/Board Member | - | - |
Seon-Wook Hwang
CEO | Chief Executive Officer | 64 | 04-11-10 |
Heon-Jong Lee
BRD | Director/Board Member | 54 | 01-04-11 |
Mun-Jin Song
BRD | Director/Board Member | 54 | 01-01-14 |
Sang-Joon Kim
BRD | Director/Board Member | 63 | 15-06-18 |
In-Gyu Lee
BRD | Director/Board Member | 67 | 13-12-17 |
Jong-Man Seol
BRD | Director/Board Member | 65 | 27-03-19 |
Gyung-Tae Kim
BRD | Director/Board Member | 67 | 21-09-16 |
Hoi-Yoon Jung
CEO | Chief Executive Officer | 45 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 090 448 | 7 443 358 ( 67,12 %) | 135 ( 0,001217 %) | 67,12 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-73,51% | 35,32 mln. | |
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,21 mld. | |
+3,23% | 22,78 mld. | |
-10,44% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-13,31% | 16,37 mld. | |
+2,44% | 13,58 mld. | |
+27,89% | 11,66 mld. |
- Beurs
- Aandelen
- Koers A229500
- Onderneming NovMetaPharma Co., Ltd.